Stellate ganglion block and its effects on the heart in ventricular tachycardia
Studies how a nerve block affects heart signals in people with ventricular tachycardia.
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Registry title
- Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
- Status
- Recruiting
- Phase
- Early phase 1
- People taking part
- 20 people, planned
- Started
- 1 Sept 2022
- Expected to end
- 1 Jul 2027
- Type of study
- Interventional
- Treatments tested
- Stellate Ganglion Block
- Record updated
- 21 November 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with ventricular tachycardia (a fast, abnormal heart rhythm) who are planned to have a catheter-based VT ablation. During the ablation, everyone gets a stellate ganglion block (a numbing injection into a nerve bundle in the neck).
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Ventricular tachycardia (VT) with a planned catheter-based VT ablation
Main reasons for not taking part
- Pregnancy
- Medical reasons against a stellate ganglion block or VT ablation
- Allergy to amide-type local anaesthetics (numbing drugs)
- Unstable blood pressure or circulation during the procedure, before the study steps start
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Planned catheter based VT ablation
- Age at least 18 years
Who cannot take part
- Hemodynamic instability during the procedure prior to the study protocol
- Hypersensitivity of local anesthetic of amide type
- Pregnancy
- Contraindication to SGB or VT ablation
Where in United States
- Hospital of the University of PennsylvaniaPhiladelphia, United StatesContact: Timothy Markman, MDTaking people
About the trial
What the trial wants to find out
Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.
The group in the trial
- Stellate ganglion blockTreatment being tested
All subjects will undergo stellate ganglion block during their VT ablation procedure
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
- Plain-language title
- Stellate ganglion block and its effects on the heart in ventricular tachycardiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 21 November 2025